Global Intravenous (IV) Solutions Industry

Sep 08, 2011, 07:03 ET from Reportlinker

NEW YORK, Sept. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Intravenous (IV) Solutions Industry

http://www.reportlinker.com/p0611078/Global-Intravenous-IV-Solutions-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_E

This report analyzes the worldwide markets for Intravenous (IV) Solutions in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 34 companies including many key and niche players such as B. Braun Melsungen AG, Baxter International, Inc., Baxter India Private Limited, Claris Lifesciences Ltd., Fresenius SE & Co. KGaA, Fresenius Kabi AG, Galenica Ltd., Grifols S.A., Hospira, Inc., Sichuan Kelun Pharmaceutical Co., Ltd., Liqvor Pharmaceuticals, Marck Biosciences Ltd., Otsuka Pharmaceutical Co. Ltd., Pfizer, Inc., Sino-Swed Pharmaceutical, Terumo Corporation, and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

2. INDUSTRY OVERVIEW 4

IV Solutions: Steady Growth Prospects 4

Current and Future Analysis 4

Healthcare Industry: Impact of Recession 5

The Need for Low-Cost Solutions 5

Clinical Nutrition - Addressing Patients' Nutritional

Requirements 5

Global Parenteral Nutrition Market 6

Table 1: Leading Players in the Global Parenteral Nutrition

Market (2010E): Percentage Share Breakdown of Value Sales for

Baxter, Fresenius Kabi, B. Braun Melsungen, Hospira, and

Others (includes corresponding Graph/Chart) 6

Peripheral Intravenous Feeding Vs Central Venous Feeding 7

Intravenous Iron Drugs Market - An Overview 7

3. AN INTRODUCTION TO INTRAVENOUS THERAPY 8

Intravenous Therapy 8

Volume Expanders - Colloids and Crystalloids 8

Blood and Blood-Based Products 8

Medications 9

4. INTRAVENOUS SOLUTIONS 10

Defining Intravenous Solutions 10

Tonicity and Osmolality 10

Production of IV Solutions 11

Types of IV Solutions 11

Colloid Solutions 11

Crystalloid Solutions 11

Properties of IV Solution Type Based on Concentration 12

Isotonic Crystalloids 12

Hypertonic Crystalloids 12

Hypotonic Crystalloids 13

Commonly Used Crystalloid Solutions 13

Saline Solution 13

Normal Saline 13

Half-Normal Saline 14

Quarter-Normal Saline 14

Hypertonic Saline 14

Dextrose 14

Saline with Additional Ingredients 14

Intravenous Sugar Solution 14

Dextrose Solutions or D5W 15

Other Types 15

Pre-mixed IV Solutions 15

Large and Small Volume Intravenous Solutions 15

Devices Used in IV Solutions Administration 16

Types of Intravenous Access Devices 16

Peripheral Cannula 17

Central IV Lines 17

Implantable Ports 17

Tunneled Lines 17

Peripherally Inserted Central Catheter (PICC) 17

IV Fluid Packaging 18

Possible Risks in Intravenous Therapy 18

Embolism 18

Electrolyte Imbalance 18

Extravasation/Infiltration 19

Phlebitis 19

Infection 19

5. INTRAVENOUS NUTRITIONAL THERAPY 20

An Introduction 20

Parenteral Nutrition 21

Routes of Application 22

Types of Parenteral Nutrition Solutions 22

Total Parenteral Nutrition (TPN) 22

Daily Requirements for Total Parenteral Nutrition in Adults 23

Partial Parenteral Nutrition (PPN) 23

Home Parenteral Nutrition 24

Classification of Parenteral Nutrition by Type of Nutrients 24

Amino Acids 24

Carbohydrates 24

Lipids 25

Minerals & Electrolytes 25

Micronutrients 26

Vitamins 26

Trace Elements 27

Large and Small Volume Parenteral (LVP) Solutions 27

Large Volume Parenteral Solutions 27

Small Volume Parenteral (SVP) Solutions 28

IV Fat Emulsions - Enabling Maintenance of Bodyweight 28

6. PRODUCT LAUNCHES 29

Bioniche Introduces Mefoxin® Premix IV Solution 29

Marck Biosciences Introduces Paracetamol IV in Plastic Pack 29

Grifols Introduces Flebogamma® 10% DIF in the US 29

Grifols Introduces Niuliva® 29

Galenica Launches Ferinject in Europe 30

B. Braun Unveils New Infusion Pumps in the US 30

7. RECENT INDUSTRY ACTIVITY 31

Pfizer Takes Over King Pharmaceuticals 31

Grifols to Set Up Form-Fill-Seal Production Lines for

Parenteral Solutions 31

FMC and Vifor Pharma Team Up to Form Vifor Fresenius 31

Marck Biosciences Snaps Up Injectible Facility of Ravish Infusion 32

Lijun Forms JV with Tonghua Dongbao Pharmaceuticals 32

ADIH and Bram S.p.A. Ink Agreement for Wellpharma's IV

Production Facility 32

Hospira Signs Multi-product Agreements with MedAssets 32

Hospira Enters into Agreements with Novation 33

Prism Pharmaceuticals Obtains FDA approval for NEXTERONE® 33

Mission Health System Commences Production of RIVA-produced IV

Solution 33

Mission Health Systems Selects Automation Solution from HIS 34

Applied Research Associates Bags Contract for Packaged

Intravenous Fluids 34

Bivigam™ Dossier Submitted to US FDA by Biotest 34

Grifols Bags EMA License for Marketing Flebogamma® DIF 100mg/ml 34

Hospira Announces Migration to Non-DEHP Based IV

Administration Units 35

Grifols and Health Robotics Ink Collaboration Agreement 35

Marck Biosciences Obtains Approval for Low Volume Parenteral

Plant 35

Grifols Receives Approval for Sterile Albumin Filling Unit 36

Grifols Establishes New Production Unit 36

Fresenius Medical to Form JV with Galenica 36

B. Braun Inks Agreement with Health Robotics 36

Fresenius Medical Care Closes Agreement with Luitpold

Pharmaceuticals 36

Grifols Receives Approval for Intravenous Immunoglobulin

Flebogamma® DIF 37

8. FOCUS ON SELECT PLAYERS 38

B. Braun Melsungen AG (Germany) 38

Baxter International, Inc. (US) 38

Baxter India Private Limited (India) 39

Claris Lifesciences Ltd. (India) 39

Fresenius SE & Co. KGaA (Germany) 39

Fresenius Kabi AG (Germany) 40

Galenica Ltd. (Switzerland) 40

Grifols S.A. (Spain) 40

Hospira, Inc. (US) 41

Sichuan Kelun Pharmaceutical Co., Ltd. 41

Liqvor Pharmaceuticals (Armenia) 42

Marck Biosciences Ltd. (India) 42

Otsuka Pharmaceutical Co. Ltd. (Japan) 42

Pfizer, Inc. (US) 43

Sino-Swed Pharmaceutical (China) 43

Terumo Corporation (Japan) 43

Watson Pharmaceuticals, Inc. (US) 44

9. GLOBAL MARKET PERSPECTIVE 45

Table 2: World Recent Past, Current and Future Analysis for

Intravenous Solutions by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific, Latin America, and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for the Years 2009 through 2017 (includes

corresponding Graph/Chart) 45

Table 3: World Historic Review for Intravenous Solutions by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,

Latin America, and Rest of World Markets Independently

Analyzed with Annual Sales Figures in US$ Million for the

Years 2003 through 2008 (includes corresponding Graph/Chart) 46

Table 4: World 15-Year Perspective for Intravenous Solutions

by Geographic Region - Percentage Breakdown of Value Sales for

US, Canada, Japan, Europe, Asia-Pacific, Latin America, and

Rest of World Markets for the Years 2003, 2010 and 2017

(includes corresponding Graph/Chart) 47

10. THE UNITED STATES 48

A.Market Analysis 48

Outlook 48

Market Overview 48

Table 5: US Population by Age Group and Gender (2010E)

(includes corresponding Graph/Chart) 48

B.Market Analytics 49

Table 6: US Recent Past, Current and Future Analysis for

Intravenous Solutions Analyzed with Annual Sales Figures in

US$ Million for the Years 2009 through 2017 (includes

corresponding Graph/Chart) 49

Table 7: US Historic Review for Intravenous Solutions

Analyzed with Annual Sales Figures in US$ Million for the

Years 2003 through 2008 (includes corresponding Graph/Chart) 49

11. CANADA 50

Market Analysis 50

Table 8: Canadian Recent Past, Current and Future Analysis

for Intravenous Solutions Analyzed with Annual Sales Figures

in US$ Million for the Years 2009 through 2017 (includes

corresponding Graph/Chart) 50

Table 9: Canadian Historic Review for Intravenous Solutions

Analyzed with Annual Sales Figures in US$ Million for the

Years 2003 through 2008 (includes corresponding Graph/Chart) 50

12. JAPAN 51

Market Analysis 51

Table 10: Japanese Recent Past, Current and Future Analysis

for Intravenous Solutions Analyzed with Annual Sales Figures

in US$ Million for the Years 2009 through 2017 (includes

corresponding Graph/Chart) 51

Table 11: Japanese Historic Review for Intravenous Solutions

Analyzed with Annual Sales Figures in US$ Million for the

Years 2003 through 2008 (includes corresponding Graph/Chart) 51

13. EUROPE 52

Market Analysis 52

Table 12: European Recent Past, Current and Future Analysis

for Intravenous Solutions by Geographic Region - France,

Germany, Italy, UK, Spain, Russia, and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for the Years 2009 through 2017 (includes

corresponding Graph/Chart) 52

Table 13: European Historic Review for Intravenous Solutions

by Geographic Region - France, Germany, Italy, UK, Spain,

Russia, and Rest of Europe Markets Independently Analyzed

with Annual Sales Figures in US$ Million for the Years 2003

through 2008 (includes corresponding Graph/Chart) 53

Table 14: European 15-Year Perspective for Intravenous

Solutions by Geographic Region - Percentage Breakdown of

Value Sales for France, Germany, Italy, UK, Spain, Russia,

and Rest of Europe Markets for the Years 2003, 2010 and 2017

(includes corresponding Graph/Chart) 54

14. ASIA-PACIFIC 55

A.Market Analysis 55

Outlook 55

IV Solutions Market in China 55

Table 15: IV Solutions Products Packaging in China (2009):

Percentage Share Breakdown of Volume Sales for Glass

Bottles, and Plastic Bottles & Non-PVC Soft Bags 55

B.Market Analytics 56

Table 16: Asia-Pacific Recent Past, Current and Future

Analysis for Intravenous Solutions Analyzed with Annual

Sales Figures in US$ Million for the Years 2009 through 2017

(includes corresponding Graph/Chart) 56

Table 17: Asia-Pacific Historic Review for Intravenous

Solutions Analyzed with Annual Sales Figures in US$ Million

for the Years 2003 through 2008 (includes corresponding

Graph/Chart) 56

15. LATIN AMERICA 57

Market Analysis 57

Table 18: Latin American Recent Past, Current and Future

Analysis for Intravenous Solutions Analyzed with Annual

Sales Figures in US$ Million for the Years 2009 through 2017

(includes corresponding Graph/Chart) 57

Table 19: Latin American Historic Review for Intravenous

Solutions Analyzed with Annual Sales Figures in US$ Million

for the Years 2003 through 2008 (includes corresponding

Graph/Chart) 57

16. REST OF WORLD 58

A.Market Analysis 58

Outlook 58

Middle East 58

Uganda 58

B.Market Analytics 59

Table 20: Rest of World Recent Past, Current and Future

Analysis for Intravenous Solutions Analyzed with Annual

Sales Figures in US$ Million for the Years 2009 through 2017

(includes corresponding Graph/Chart) 59

Table 21: Rest of World Historic Review for Intravenous

Solutions Analyzed with Annual Sales Figures in US$ Million

for the Years 2003 through 2008 (includes corresponding

Graph/Chart) 59

COMPETITIVE LANDSCAPE

Total Companies Profiled: 34 (including Divisions/Subsidiaries - 46)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 13

Canada 1

Japan 1

Europe 14

France 2

Germany 5

The United Kingdom 2

Spain 1

Rest of Europe 4

Asia-Pacific (Excluding Japan) 15

Middle-East 1

Africa 1

------------------------------------------

To order this report:

Medical Equipment and Supply Industry: Global Intravenous (IV) Solutions Industry

Medical Equipment and Supply Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com